Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
Blood|November 13, 2004
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, et al.
Molecular Immunology|December 21, 2004
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysisDaniela Pende, Cristina Bottino, Roberta Castriconi, et al.
Journal of Medical Genetics|August 28, 2010
STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5Valentina Cetica, Alessandra Santoro, Kimberly C Gilmour, et al.
Blood Advances|May 27, 2020
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 moleculesChiara Barberi, Claudia De Pasquale, Alessandro Allegra, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2015
Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registryValentina Cetica, Elena Sieni, Daniela Pende, et al.
European Journal of Immunology|April 8, 2017
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patientsRaffaella Meazza, Michela Falco, Stefania Marcenaro, et al.
Blood|March 21, 2007
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive valueLoredana Ruggeri, Antonella Mancusi, Marusca Capanni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2016
Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic PotentialMonique M van Ostaijen-ten Dam, Henk-Jan Prins, Gerharda H Boerman, et al.
Blood|October 24, 2008
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityDaniela Pende, Stefania Marcenaro, Michela Falco, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
Blood|November 13, 2004
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, et al.
Molecular Immunology|December 21, 2004
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysisDaniela Pende, Cristina Bottino, Roberta Castriconi, et al.
Journal of Medical Genetics|August 28, 2010
STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5Valentina Cetica, Alessandra Santoro, Kimberly C Gilmour, et al.
Blood Advances|May 27, 2020
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 moleculesChiara Barberi, Claudia De Pasquale, Alessandro Allegra, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2015
Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registryValentina Cetica, Elena Sieni, Daniela Pende, et al.
European Journal of Immunology|April 8, 2017
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patientsRaffaella Meazza, Michela Falco, Stefania Marcenaro, et al.
Blood|March 21, 2007
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive valueLoredana Ruggeri, Antonella Mancusi, Marusca Capanni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2016
Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic PotentialMonique M van Ostaijen-ten Dam, Henk-Jan Prins, Gerharda H Boerman, et al.
Blood|October 24, 2008
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityDaniela Pende, Stefania Marcenaro, Michela Falco, et al.
Pageof 11